New anti-seizure medication for elderly epileptic patients

References

• World Health Organization. Neurological disorders: public health challenges. Geneva, Switzerland: World Health Organization; 2006.
   Google Scholar
• Craig I, Tallis R. Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single‐blind randomized comparative study. Epilepsia. 1994 Mar;35(2):381–390.
   PubMed Web of Science ®Google Scholar
• Sillanpää M, Kälviäinen R, Klaukka T, et al. Temporal changes in the incidence of epilepsy in Finland: nationwide study. Epilepsy Res. 2006 Oct 1;71(2–3):206–215.
   PubMed Web of Science ®Google Scholar
• Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940–1980. Epilepsia. 1991 Aug;32(4):429–445.
   PubMed Web of Science ®Google Scholar
• Kim DW, Oh J. Comparison of new‐onset and persistent epilepsy in the elderly. Acta Neurol Scand. 2019 Apr;139(4):395–398.
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Elder AT, Kwan P. Epilepsy in later life. Lancet Neurol. 2009 Nov 1;8(11):1019–1030.
   PubMed Web of Science ®Google Scholar
• So EL, Annegers JF, Hauser WA, et al. Population-based study of seizure disorders after cerebral infarction. Neurology. 1996 Feb 1;46(2):350–355.
   PubMed Web of Science ®Google Scholar
• Hommet C, Mondon K, Camus V, et al. Epilepsy and dementia in the elderly. Dement Geriatr Cogn Disord. 2008;25(4):293–300.
   PubMed Web of Science ®Google Scholar
• Arabi M, Dirani M, Hourani R, et al. Frequency and stratification of epileptogenic lesions in elderly with new onset seizures. Front Neurol. 2018;9.
   PubMed Web of Science ®Google Scholar
• Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology. 2004 Mar 9;62(5 suppl 2):S24–9.
   PubMed Web of Science ®Google Scholar
• Wieshmann UC. Clinical application of neuroimaging in epilepsy. J Neurol Neurosurg. 2003 Apr 1;74(4):466–470.
   Web of Science ®Google Scholar
• Drury I, Beydoun A. Interictal epileptiform activity in elderly patients with epilepsy. Electroencephalography Clin Neuropharmacol. 1998 Apr 1;106(4):369–373.
   PubMedGoogle Scholar
• McBride AE, Shih TT, Hirsch LJ. Video‐EEG monitoring in the elderly: a review of 94 patients. Epilepsia. 2002 Feb;43(2):165–169.
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Kwan P. Epilepsy in elderly people. Bmj. 2005 Dec 1;331(7528):1317–1322.
   PubMed Web of Science ®Google Scholar
• Curran S, de Pauw K. Selecting an antidepressant for use in a patient with epilepsy. Drug Saf. 1998;18(2):125–133.
   PubMed Web of Science ®Google Scholar
• Harden CL, Goldstein MAJCD. Mood disorders in patients with epilepsy. CNS Drugs. 2002;16(5):291–302.
   Google Scholar
• Taylor D, Paton C, Kapur S. South London and Maudsley NHS Trust. The Maudsley prescribing guidelines in psychiatry, editor. Chichester, West Sussex: Wiley-Blackwell; 2015.
   Google Scholar
• Brigo F. Selecting the appropriate pharmacotherapy for epilepsy in patients with Alzheimer’s disease. Expert Opin Pharmacother. 2018;19(16):1739–1741.
   PubMed Web of Science ®Google Scholar
• Ruiz-Giménez J, Sanchez-Alvarez J, Cañadillas-Hidalgo F, et al. Antiepileptic treatment in patients with epilepsy and other comorbidities. Seizure. 2010;19(7):375–382.
   PubMed Web of Science ®Google Scholar
• Pack AM. Treatment of epilepsy to optimize bone health. Curr Treat Options Neurol. 2011 Aug 1;13(4):346–354.
   PubMed Web of Science ®Google Scholar
• Perucca E, Berlowitz D, Birnbaum A, et al. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res. 2006;68:49–63.
   PubMed Web of Science ®Google Scholar
• Consoli D, Bosco D, Postorino P, et al. Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project). Cerebrovascular Dis. 2012;34(4):282–289.
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Overstall PW, Giorgi L, UK Lamotrigine Elderly Study Group. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res. 1999 Oct 1;37(1):81–87.
   PubMed Web of Science ®Google Scholar
• Saetre E, Perucca E, Isojärvi J, et al., LAM 40089 Study Group. An international multicenter randomized double‐blind controlled trial of lamotrigine and sustained‐release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia. 2007 Jul;48(7):1292–1302.
   PubMed Web of Science ®Google Scholar
• Rowan AJ, Ramsay RE, Collins JF, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology. 2005 Jun 14;64(11):1868–1873.
   PubMed Web of Science ®Google Scholar
• Gilad R, Sadeh M, Rapoport A, et al. Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure. Clin Neuropharmacol. 2007 Jul 1;30(4):189–195.
   PubMed Web of Science ®Google Scholar
• Pohlmann-Eden B, Marson AG, Noack-Rink M, et al. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study. BMC Neurol. 2016 Dec;16(1):149.
   PubMedGoogle Scholar
• Ferrendelli JA, French J, Leppik I, et al. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial. Epilepsy Behavi. 2003 Dec 1;4(6):702–709.
   PubMed Web of Science ®Google Scholar
• Alsaadi TM, Koopmans S, Apperson M, et al. Levetiracetam monotherapy for elderly patients with epilepsy. Seizure. 2004 Jan 1;13(1):58–60.
   PubMed Web of Science ®Google Scholar
• Garcia-Escriva A, Lopez-Hernandez N. The use of levetiracetam in monotherapy in post-stroke seizures in the elderly population. Rev Neurol. 2007;45(9):523–525.
   PubMed Web of Science ®Google Scholar
• Stefan H, Hubbertz L, Peglau I, et al. Epilepsy outcomes in elderly treated with topiramate. Acta Neurol Scand. 2008 Sep;118(3):164–174.
   PubMed Web of Science ®Google Scholar
• Grošelj J, Guerrini R, Van Oene J, et al., TOP‐INT‐51 Investigators’ Group. Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy. Acta Neurol Scand. 2005 Sep;112(3):144–150.
   PubMed Web of Science ®Google Scholar
• Belcastro V, Vidale S, Pierguidi L, et al. Intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly: a proof-of-concept, observational study. Seizure. 2013 Dec 1;22(10):905–907.
   PubMed Web of Science ®Google Scholar
• Ramsay RE, Sabharwal V, Khan F, et al. Safety & pK of IV loading dose of lacosamide in the ICU. Epilepsy Behav. 2015 Aug 1;49:340–342.
   PubMed Web of Science ®Google Scholar
• Rainesalo S, Mäkinen J, Raitanen J, et al. Clinical management of elderly patients with epilepsy; the use of lacosamide in a single center setting. Epilepsy Behavi. 2017 Oct 1;75:86–89.
   PubMed Web of Science ®Google Scholar
• Trinka E, Segieth J, Giorgi L. Tolerability and safety of zonisamide in elderly patients with partial epilepsy: results of a pooled analysis. J Neurol Neurosurg Psychiatry. 2013 Nov 1;84(11):e2.216–e2.
   PubMed Web of Science ®Google Scholar
• Sarkis RA, Nicolas J, Lee JW. Tolerability of lacosamide or zonisamide in elderly patients with seizures. Seizure. 2017 Jul 1;49:1–4.
   PubMed Web of Science ®Google Scholar
• Doğan EA, Genç E, Genç BO, et al. Efficacy, tolerability, and retention rates of zonisamide in older adult patients with focal-onset epilepsy: experiences from two tertiary epilepsy centers. Epilepsy Behav. 2017 Nov 1;76(76):19–23.
   PubMedGoogle Scholar
• Leppik IE, Wechsler RT, Williams B, et al. Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trials. Epilepsy Res. 2015 Feb 1;110:216–220.
   PubMed Web of Science ®Google Scholar
• Costa R, Steinhoff B, Gama H, et al. Safety, tolerability and efficacy of eslicarbazepine acetate as adjunctive therapy in patients aged ≥65 years with focal seizures. Drugs Aging. 2018 Dec 1;35(12):1109–1117.
   PubMed Web of Science ®Google Scholar
• Gómez-Ibáñez A, Serratosa JM, Guillamón E, et al. Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: case series. Seizure. 2017 May 1;48:53–56.
   PubMed Web of Science ®Google Scholar
• Kutluay E, McCague K, D’Souza J, et al. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav. 2003;4(2):175–180.
   PubMed Web of Science ®Google Scholar
• Dogan EA, Usta BE, Bilgen R, et al. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study ın adult and elderly patients with newly diagnosed partial epilepsy. Epilepsy Behav. 2008;13(1):156–161.
   PubMed Web of Science ®Google Scholar
• Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):522–530.
   PubMed Web of Science ®Google Scholar
• Thijs RD, Surges R, O’Brien TJ, et al. Epilepsy in adults. Lancet. 2019 Jan;393(10172):689–701.
   PubMed Web of Science ®Google Scholar
• Guerrini R, Dravet C, Genton P, et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia. 1998;39(5):508–512.
   PubMed Web of Science ®Google Scholar